Bifogade filer
        
        
    
        
            
                Kurs
            
            
            
                +33,33%
            
            
        
    
    
    
            
            
    
            
                
                    Likviditet
                
            0,63 MSEK
        
    
    
    Kalender
| Est. tid* | ||
| 2026-02-25 | 08:20 | Bokslutskommuniké 2025 | 
| 2025-11-06 | 08:30 | Kvartalsrapport 2025-Q3 | 
| 2025-08-13 | - | Kvartalsrapport 2025-Q2 | 
| 2025-06-26 | - | Årsstämma | 
| 2025-05-28 | - | Kvartalsrapport 2025-Q1 | 
| 2025-05-21 | - | X-dag ordinarie utdelning PMED 0.00 SEK | 
| 2025-02-28 | - | Bokslutskommuniké 2024 | 
| 2025-01-07 | - | Extra Bolagsstämma 2024 | 
| 2024-11-06 | - | Kvartalsrapport 2024-Q3 | 
| 2024-08-15 | - | Kvartalsrapport 2024-Q2 | 
| 2024-05-22 | - | X-dag ordinarie utdelning PMED 0.00 SEK | 
| 2024-05-21 | - | Årsstämma | 
| 2024-05-07 | - | Kvartalsrapport 2024-Q1 | 
| 2024-02-23 | - | Bokslutskommuniké 2023 | 
| 2024-01-11 | - | Extra Bolagsstämma 2023 | 
| 2023-10-24 | - | Kvartalsrapport 2023-Q3 | 
| 2023-08-11 | - | Kvartalsrapport 2023-Q2 | 
| 2023-04-24 | - | Kvartalsrapport 2023-Q1 | 
| 2023-04-21 | - | X-dag ordinarie utdelning PMED 0.00 SEK | 
| 2023-04-20 | - | Årsstämma | 
| 2023-02-24 | - | Bokslutskommuniké 2022 | 
| 2023-01-09 | - | Extra Bolagsstämma 2022 | 
| 2022-11-10 | - | Kvartalsrapport 2022-Q3 | 
| 2022-08-18 | - | Kvartalsrapport 2022-Q2 | 
| 2022-05-25 | - | X-dag ordinarie utdelning PMED 0.00 SEK | 
| 2022-05-24 | - | Årsstämma | 
| 2022-05-12 | - | Kvartalsrapport 2022-Q1 | 
| 2022-02-25 | - | Bokslutskommuniké 2021 | 
| 2021-12-16 | - | Extra Bolagsstämma 2021 | 
| 2021-11-10 | - | Kvartalsrapport 2021-Q3 | 
| 2021-08-18 | - | Kvartalsrapport 2021-Q2 | 
| 2021-06-10 | - | X-dag ordinarie utdelning PMED 0.00 SEK | 
| 2021-05-27 | - | Årsstämma | 
| 2021-05-12 | - | Kvartalsrapport 2021-Q1 | 
| 2021-02-26 | - | Bokslutskommuniké 2020 | 
| 2020-11-10 | - | Kvartalsrapport 2020-Q3 | 
| 2020-08-17 | - | Kvartalsrapport 2020-Q2 | 
| 2020-07-28 | - | Extra Bolagsstämma 2020 | 
| 2020-06-30 | - | Årsstämma | 
| 2020-06-17 | - | X-dag ordinarie utdelning PMED 0.00 SEK | 
| 2020-05-14 | - | Kvartalsrapport 2020-Q1 | 
| 2020-02-27 | - | Bokslutskommuniké 2019 | 
| 2019-11-08 | - | Kvartalsrapport 2019-Q3 | 
| 2019-08-16 | - | Kvartalsrapport 2019-Q2 | 
| 2019-06-20 | - | X-dag ordinarie utdelning PMED 0.00 SEK | 
| 2019-06-19 | - | Årsstämma | 
| 2019-05-15 | - | Kvartalsrapport 2019-Q1 | 
| 2019-02-27 | - | Bokslutskommuniké 2018 | 
| 2018-11-09 | - | Kvartalsrapport 2018-Q3 | 
| 2018-08-17 | - | Kvartalsrapport 2018-Q2 | 
| 2018-05-15 | - | Kvartalsrapport 2018-Q1 | 
| 2018-03-29 | - | X-dag ordinarie utdelning PMED 0.00 SEK | 
| 2018-03-28 | - | Årsstämma | 
| 2018-02-27 | - | Bokslutskommuniké 2017 | 
| 2017-11-09 | - | Kvartalsrapport 2017-Q3 | 
| 2017-08-17 | - | Kvartalsrapport 2017-Q2 | 
| 2017-05-19 | - | X-dag ordinarie utdelning PMED 0.00 SEK | 
| 2017-05-18 | - | Årsstämma | 
| 2017-05-16 | - | Kvartalsrapport 2017-Q1 | 
| 2017-02-27 | - | Bokslutskommuniké 2016 | 
| 2016-11-10 | - | Kvartalsrapport 2016-Q3 | 
| 2016-08-17 | - | Kvartalsrapport 2016-Q2 | 
| 2016-07-22 | - | Extra Bolagsstämma 2016 | 
| 2016-05-20 | - | X-dag ordinarie utdelning PMED 0.00 SEK | 
| 2016-05-19 | - | Årsstämma | 
| 2016-05-17 | - | Kvartalsrapport 2016-Q1 | 
| 2016-02-26 | - | Bokslutskommuniké 2015 | 
| 2015-11-19 | - | Extra Bolagsstämma 2015 | 
| 2015-11-11 | - | Kvartalsrapport 2015-Q3 | 
| 2015-08-17 | - | Kvartalsrapport 2015-Q2 | 
| 2015-05-08 | - | Kvartalsrapport 2015-Q1 | 
| 2015-04-10 | - | X-dag ordinarie utdelning PMED 0.00 SEK | 
| 2015-04-09 | - | Årsstämma | 
| 2015-02-27 | - | Bokslutskommuniké 2014 | 
| 2014-10-15 | - | Kvartalsrapport 2014-Q3 | 
| 2014-08-13 | - | Kvartalsrapport 2014-Q2 | 
Beskrivning
| Land | Sverige | 
|---|---|
| Lista | Spotlight | 
| Sektor | Hälsovård | 
| Industri | Bioteknik | 
Peptonic Medical AB (publ) ("Peptonic" or the "Company") has received part of the first order under the recently signed strategic distribution agreement with US-based Joylux Inc. The order relates to the Company's product VagiVital AktivGel and amounts to USD 126,000. Work on design and artwork under the Joylux brand has commenced.
Joylux is a well-established player in women's intimate self-care during and after menopause, with a strong brand, broad market presence, and an engaged community. Joylux offers effective intimate care products and innovative digital solutions that enhance women's intimate health, and collaborates with well-known ambassadors and partners such as Respin, a company founded by actress and activist Halle Berry.
As part of the collaboration, Peptonic will supply selected products marketed and sold under the Joylux brand in the USA, Canada, Mexico, and the UK. Peptonic can now confirm that part of the first order has been received and that work on product design and artwork is well underway.
For further information, please contact:
Anna Linton, CEO, Peptonic Medical AB                                            
Email: anna.linton@peptonicmedical.se
Phone: +46 70-244 92 07
About Peptonic Medical AB
PEPTONIC medical AB (publ) is a pioneering Swedish medtech company specializing in the development and sale of clinically proven self-care products for women's intimate health. Through its brands VagiVital and Vernivia, the Company offers a broad over-the-counter portfolio of effective and gentle products designed to help women understand, treat, and prevent common medical conditions in the intimate area.
Peptonic's growth strategy centers on geographic expansion, particularly in the U.S. and Europe, while continually enhancing its product portfolio through in-house development and strategic acquisitions.
The Company is headquartered in Stockholm, Sweden, and operates the subsidiaries, Peptonic Medical Inc. and Common Sense Marketing Inc., in the U.S. Peptonic Medical was founded in 2009 and has been listed on the Spotlight Stock Market since 2014.